###### Strengths and limitations of this study

-   This is the first meta-analysis providing comprehensive assessment on the prevalence of post-traumatic stress disorder (PTSD) among adults living with HIV.

-   Several subgroup analyses were conducted to examine the influence of diverse sociodemographic backgrounds as well as methodological heterogeneity.

-   This review was conducted with specific definitions of PTSD as part of the inclusion criteria to help in acquiring high level of evidence, which also limited the number of eligible studies.

-   A lack of studies carried out on the topic in low-income and middle-income countries could underestimate the burden of HIV-PTSD prevalence of the world.

-   We did not undertake a search of grey literature, restricting our sample to articles published in peer-reviewed journals.

Introduction {#s1}
============

Globally, there were \>36 million people living with HIV (PLWH) by the end of 2017.[@R1] Although increasingly expanded access to antiretroviral therapy (ART) has led to a prolonged life span, a large portion of PLWH still suffer a significant burden due to psychiatric disorders.[@R2] Post-traumatic stress disorder (PTSD) is a mental health condition following exposure to a life-threatening event, or extreme or repeated exposure to traumatic events.[@R4] A growing body of literature indicates that PLWH have a heightened risk for PTSD.[@R5] PLWH are more likely to report a history of traumatic and stressful life experiences than the general population, including childhood sexual/physical abuse and intimate partner violence.[@R7] PTSD may precede an HIV-positive diagnosis due to previous traumatic experiences. In addition, being diagnosed with HIV, a life-threatening illness, is a potentially traumatic event in and of itself, and PTSD may emerge as a result of this diagnosis. Infection with HIV causes a progressive destruction of the immune system, which increases the susceptibility to malignancies that threaten a person's life, and being labelled and associated with HIV stigma, taking multiple daily medications and experiencing repeated unpleasant side effects constitute potentially traumatic events.[@R10] These high rates of potential trauma exposure during the course of the illness may also increase the likelihood of developing PTSD.

Generally, the concept of PTSD has been broadly applied to military veterans, survivors of disasters and accidents and victims of violent assaults. PTSD as a serious and costly health problem in the general population is well recognised, and impairs a person's physical health, and greatly influences social functioning.[@R11] The co-occurrence of PTSD and HIV-infection creates even more challenges regarding both the treatment of PTSD and the management of HIV. PTSD can negatively impact medication adherence and impair immune functioning,[@R12] both of which are especially critical for PLWH. PLWH with PTSD have been found to be at increased risk of somatisation and physical disorders.[@R16] The illness experience of PTSD, such as persistent avoidance and re-experiencing the traumatic event, may also compromise quality of life and cause significant distress in PLWH.[@R7] Subsequently, prolonged and untreated PTSD may lead to exacerbation of PTSD as well as HIV progression.[@R18] There is also evidence suggesting that reductions in PTSD symptom severity are related to improved HIV-related outcomes.[@R19] Given that PTSD elevates HIV risk behaviours[@R20] and the possibility of HIV transmission also increases along with disease progression, PLWH suffering from PTSD are an important group to understand and with whom to intervene.

Valid data on PTSD prevalence among PLWH are essential. Evidence on the extent of PTSD among PLWH is needed to raise awareness and recommend clinical management. Although a number of studies have investigated the prevalence of PTSD in PLWH, findings have been inconsistent.[@R22] While studies have reported varied incidence, few efforts have been made to aggregate existing research using meta-analysis techniques. There was one published meta-analysis estimating the pooled prevalence of PTSD among women living with HIV in 2012.[@R23] But the lack of studies with other groups lowered the generalisability and global relevance of their findings. Moreover, the meta-analysis was conducted in 2012, and the increase of publications about PTSD among PLWH since then[@R24] suggests that a timely update is urgently needed. Indeed, several reviews provide a useful overview of the possible prevalence of PTSD among PLWH[@R22]; however, a number of gaps remain. First, to date, there has been no attempt to achieve a better understanding of the epidemiology of PTSD in PLWH and the reviews did not aim at an overall PTSD prevalence specifically. Second, economically and politically, while precise estimates of prevalence can support efficient allocation of resources, factors that might influence PTSD prevalence, such as population characteristics and sociocultural context have been neglected.

Therefore, to fill these knowledge gaps, we aimed to provide an estimate for the worldwide prevalence of PTSD in PLWH and to test whether PTSD prevalence in PLWH differs based between population groups, country income groups and study characteristics. This information can then be used to inform further practice and research for this highly comorbid group.

Methods {#s2}
=======

Search strategy {#s2-1}
---------------

Systematic searches were conducted through five electronic English databases (Medline, Web of Science, CINAHL, EMBASE and Cochrane Library) and three Chinese databases (CNKI, Wanfang Database, Sinomed) to identify published studies on PTSD prevalence among PLWH from January 2000 to November 2019. The search terms were: posttrauma\*, post trauma\*, post-trauma\*, stress disorder\*, OR PTSD; AND HIV, acquired immunodeficiency syndrome, AIDS, OR PLWH\$; AND epidemiology, occurrence, incidence, OR prevalence (see [online supplementary appendix 1](#SP1){ref-type="supplementary-material"} for the precise search strategy). The reference lists of review articles and retrieved full-text articles were also examined for additional papers that were eligible for this review.
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Eligibility criteria {#s2-2}
--------------------

Studies were included for this meta-analysis if they met the following predetermined selection criteria: (1) published in Chinese or English in a peer-reviewed journal; (2) observational study where prevalence figures for PTSD were stated or can be calculated in an adult HIV population and (3) underlined that PTSD cases were identified in accordance with the Diagnostic and Statistical Manual of Mental Disorders (DSM) or the International Classification of Diseases (ICD) diagnostic criteria.[@R28] Studies were excluded if (1) they only recruited those who had mental distress; (2) they specifically targeted only youth under 18 or children affected by HIV. No restriction was applied regarding gender, nationality or sexual orientation. Additionally, articles were reviewed closely, and if repeated data were observed, only the earlier publication with one set of complete data was included.

Data extraction and analysis {#s2-3}
----------------------------

Screening of papers was carried out by three of the authors (CT, JM and XX) following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations. CT and XX searched the English papers and JM screened the Chinese language papers. After duplicates were deleted, each investigator read titles and abstracts closely to capture all potential studies. Full-text articles were obtained and reviewed for all criteria. Any discrepancies were resolved by discussion with the research team. The PRISMA flow chart shows the results of the systematic search ([figure 1](#F1){ref-type="fig"}).

![Flow chart of study inclusion. PLWH, people living with HIV; PTSD, post-traumatic stress disorder.](bmjopen-2019-032435f01){#F1}

Data extraction {#s2-4}
---------------

Two authors (CT and XX) used a data extraction sheet to capture the following data independently from included papers: first author, year of publication, country of study, sampling method, sample size, number of patients with PTSD, measurements and outcome data. The third investigator (HW) helped to verify all extracted data and resolve any uncertainties. To facilitate detection of sample/methodological heterogeneity, countries were categorised according to their income level, and measurements were classified into diagnostic questionnaire and clinical interview based on the approach to diagnosing PTSD. To minimise selection bias, we reviewed the articles included in the meta-analysis to ensure they met eligibility criteria. Gender and sexual orientation were considered because of underlying differences in the epidemics of HIV and trauma.[@R30] Specifically, populations were grouped as women and men, and samples of HIV-infected men were further classified into men who have sex with men (MSM) and non-MSM males.

Assessment of methodological quality {#s2-5}
------------------------------------

We used the quality assessment forms for cross-sectional/prevalence studies recommended by the US Agency for Healthcare Research and Quality (AHRQ)[@R33] to assess the reliability of the eligible studies. The checklist included 11 items. Each item was coded with a 'yes/no/unclear': 'no' or 'unclear' was scored '0', and 'yes' was scored '1'. Consistent with previous meta-analysis studies using the AHRQ assessments, a total score of 8--11, 4--7 and 0--3 indicated high, moderate and low quality, respectively.

Meta-analysis {#s2-6}
-------------

In this study, all statistical analyses were performed using Stata V.12.0 software (STATA, College Station, Texas, USA).[@R34] Heterogeneity was tested and quantified by the χ^2^ Q statistic and the I^2^ statistic. The prevalence of PTSD among PLWH were combined and reported as proportions with corresponding 95% CIs. The pooled prevalence was estimated using a random-effects model when heterogeneity was statistically significant (I^2^\>50%, p≤0.10). Otherwise, a fix-effects model was used.[@R35]As sources of heterogeneity may arise from sociodemographic and methodological factors, subgroup analyses were performed by (1) economic levels of the study country, (2) gender/sexual orientation, (3) sampling method and (4) assessment method for PTSD, when enough data were available; χ^2^ tests were further used to investigate whether there were significant differences between groups. We only performed these subgroup analyses when data were extractable and sufficient. Separate sensitivity analyses were used for studies with low quality to examine the stability of the pooled prevalence. Publication bias was assessed using the Egger's and the Begg's tests.[@R36] Significance level of p values \<0.05 were employed for all analyses.

Patient and public involvement {#s2-7}
------------------------------

Patients and the public were not involved in this study.

Results {#s3}
=======

Search results {#s3-1}
--------------

A total of 2396 records were identified by the electronic bibliographic database searches. Ten additional manuscripts were identified through other sources (eg, reference lists of review papers). From an initial screen of 2301 records after duplicates were removed, 2185 records were excluded on basis of title or abstract because those studies were not relevant to this review (n=2107) or were reviews/commentary (n=78). The remaining 116 full articles were selected for the eligibility assessment. Of those, 7 were excluded for repeated data, 9 were excluded for targeting PLWH who received psychological intervention or suffered from genocide/natural disaster and 62 were excluded for not reporting the PTSD prevalence among PLWH. Finally, a total of 38 studies[@R14] met inclusion criteria and were included in this meta-analysis. Search results are elaborated in [figure 1](#F1){ref-type="fig"}.

Study characteristics {#s3-2}
---------------------

Most of the papers (84.3%) scored 4 or more according to the AHRQ scale indicating a generally moderate to high level of data quality ([online supplementary appendix 2](#SP2){ref-type="supplementary-material"}). [Table 1](#T1){ref-type="table"} shows the characteristics of the included studies. These studies were published between 2002[@R72] and 2019.[@R38] Geographically, over half (n=21, 55.3%) of the 38 included studies were conducted in the USA, followed by South Africa (n=6, 15.8%), China (n=3, 7.9%), the UK (n=2, 5.3%), Rwanda (n=1, 2.6%) and low-income countries including Gambia (n=1, 2.6%), Nigeria (n=1, 2.6%), Uganda (n=1, 2.6%), Haiti (n=1, 2.6%) and Zimbabwe (n=1, 2.6%). Twenty-five studies (65.8%) measured PTSD using diagnostic self-report questionnaires, while the other 13 studies (34.2%) conducted clinical interviews to diagnose PTSD. Though eight studies (21.1%) did not report their sampling methods, convenience sampling methods were adopted in most studies (n=20, 52.6%), followed by consecutive sampling (n=7, 18.4%), and probability sampling (n=3, 7.9%). In all, 11743 PLWH were involved (sample size varied from 41 to 1489), of which 2742 were identified with PTSD.
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###### 

Characteristics of the included studies

  Study                           Location of study   Sampling methods       Sample size   No. of patients with PTSD   Measurements     Data collection             Quality
  ------------------------------- ------------------- ---------------------- ------------- --------------------------- ---------------- --------------------------- ----------
  Fabian *et al*[@R38]            USA                 Convenience sampling   238           80                          PCL-C            Self-report questionnaire   Moderate
  Chen *et al*[@R39]              China               Unclear                535           142                         PCL-C            Self-report questionnaire   Moderate
  Spies *et al*[@R40]             South Africa        Convenience sampling   68            10                          DTS              Self-report questionnaire   Moderate
  Verhey *et al*[@R41]            Zimbabwe            Random sampling        91            22                          CAPS             Clinical interview          Moderate
  Gao *et al*[@R42]               China               Convenience sampling   520           89                          PCL-C            Self-report questionnaire   Moderate
  McLean *et al*[@R43]            USA                 Convenience sampling   42            12                          PSS              Clinical interview          Moderate
  Kemppainen *et al*[@R25]        USA                 Convenience sampling   60            26                          PCL-C            Self-report questionnaire   Low
  Gonzalez *et al*[@R24]          USA                 Convenience sampling   137           47                          PDS              Self-report questionnaire   Moderate
  Rubin *et al*[@R44]             USA                 Convenience sampling   1004          174                         PCL-C            Self-report questionnaire   Moderate
  John *et al*[@R45]              USA                 Consecutive sampling   359           44                          Breslau          Self-report questionnaire   Moderate
  Siyahhan Julnes *et al*[@R14]   USA                 Convenience sampling   114           39                          CDQ              Self-report questionnaire   Moderate
  Zhang *et al*[@R46]             China               Convenience sampling   243           106                         PCL-C            Self-report questionnaire   Low
  Battaglia *et al*[@R47]         USA                 Convenience sampling   200           72                          PTSD checklist   Self-report questionnaire   Moderate
  Hansrod *et al*[@R48]           South Africa        Convenience sampling   114           29                          MINI             Clinical interview          Moderate
  Brownley *et al*[@R49]          USA                 Unclear                220           78                          PSS              Self-report questionnaire   Moderate
  Malee *et al*[@R50]             USA                 Convenience sampling   1223          281                         CDQ              Self-report questionnaire   High
  Glémaud *et al*[@R51]           USA                 Unclear                96            33                          PRIME MD PHQ     Clinical interview          Low
  Gore-Felton *et al*[@R52]       USA                 Convenience sampling   94            28                          PCL-C            Self-report questionnaire   Low
  Glover *et al*[@R53]            USA                 Convenience sampling   99            24                          PDS              Self-report questionnaire   High
  Dévieux *et al*[@R54]           Haiti               Convenience sampling   104           52                          PCL-C            Self-report questionnaire   Moderate
  Gard *et al*[@R55]              Rwanda              Unclear                705           380                         HTS              Self-report questionnaire   Moderate
  Peterson *et al*[@R56]          Gambia              Consecutive sampling   153           46                          IES-R            Self-report questionnaire   High
  Kinyanda *et al*[@R57]          Uganda              Consecutive sampling   618           10                          MINI             Clinical interview          Moderate
  Bogart *et al*[@R58]            USA                 Convenience sampling   181           72                          PDS              Self-report questionnaire   Moderate
  Martin *et al*[@R59]            UK                  Convenience sampling   85            46                          CIDI             Clinical interview          Moderate
  Reisner *et al*[@R60]           USA                 Convenience sampling   63            16                          AUDADIS-IV       Clinical interview          Moderate
  Theuninck *et al*[@R61]         UK                  Convenience sampling   100           33                          PCL-C            Self-report questionnaire   Low
  Joska *et al*[@R62]             South Africa        Unclear                536           164                         HTS              Self-report questionnaire   Moderate
  Adewuya *et al*[@R63]           Nigeria             Unclear                190           52                          MINI             Clinical interview          Moderate
  Spies *et al*[@R64]             South Africa        Unclear                429           92                          MINI             Clinical interview          Moderate
  Fincham *et al*[@R65]           South Africa        Consecutive sampling   456           23                          MINI             Clinical interview          Moderate
  Zanjani *et al*[@R66]           USA                 Random sampling        109           13                          MINI             Clinical interview          Moderate
  Israelski *et al*[@R67]         USA                 Unclear                210           71                          PCL-C            Self-report questionnaire   Low
  Boarts *et al*[@R68]            USA                 Convenience sampling   57            24                          PDS              Self-report questionnaire   Moderate
  Leserman *et al*[@R69]          USA                 Consecutive sampling   611           98                          PTSD checklist   Self-report questionnaire   High
  Olley *et al*[@R70]             South Africa        Consecutive sampling   149           42                          MINI             Clinical interview          Moderate
  Vitiello *et al*[@R71]          USA                 Probability sample     1489          155                         CIDI             Clinical interview          Moderate
  Martinez *et al*[@R72]          USA                 Consecutive sampling   41            17                          PCL-C            Self-report questionnaire   Moderate

\*Total number of adults living with HIV.

AUDADIS-IV, The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV; CAPS, Clinician Administered Post-traumatic Stress scale; CDQ, Client Diagnostic Questionnaire; CIDI, Clinical Interview for Diagnosis for DSM-IV; DIS-IV, Diagnostic Interview Schedule for DSM-IV diagnoses; DTS, Davidson Trauma Scale; HTS, Harvard Trauma Scale; IES-R, Impact of Event Scale-Revised; MINI, Mini-International Neuropsychiatric Interview; PCL-C, Post-traumatic Stress Disorder Checklist-Civilian Version; PDS, Post-traumatic Stress Diagnostic Scale⁠---Self-report version; PRIME MD PHQ, Primary Care Evaluation of Mental Disorders Patient Health Questionnaire; PSS, Post-traumatic Stress Symptom Scale; PTSD checklist, post-traumatic stress disorder checklist.

Prevalence of PTSD in PLWH {#s3-3}
--------------------------

The reported prevalence of PTSD in PLWH ranged from 1.6%[@R57] to 54.1%.[@R59] The overall pooled prevalence was 28% (95% CI 24% to 33%), estimated by a random-effects model, as significant heterogeneity (p≤0.001, I^2^=98.1%) was observed among the included studies. Meta-analyses are shown as forest plots ([figure 2](#F2){ref-type="fig"}).

![Forest plot presenting the prevalence of post-traumatic stress disorder (PTSD) in people living with HIV (PLWH).](bmjopen-2019-032435f02){#F2}

Publication bias and sensitivity analysis {#s3-4}
-----------------------------------------

Possible publication bias was indicated according to the results of Egger's linear test (t=6.84, p\<0.05) and Begg's rank test (z=0.58, p=0.56). However, low sensitivity was suggested with the pooled prevalence of PTSD changed slightly from 28% (95% CI 24% to 33%) to 27% (95% CI 22% to 32%) after excluding low-quality articles.

Subgroup analyses {#s3-5}
-----------------

The results of subgroup analyses are shown in [table 2](#T2){ref-type="table"}. The prevalence of PTSD in PLWH differed significantly by geographic area, population group, sampling and measurement method. Specifically, the proportion of PLWH with PTSD in high-income countries tended to be higher (pooled rate=29%, 95% CI 25% to 34%) than middle-income countries (pooled rate=27%, 95% CI 16% to 37%) and low-income countries (pooled rate=26%, 95% CI 7% to 45%). Studies using clinical interviews reported lower rates of PTSD (pooled rate=22%, 95% CI 16% to 27%) compared with those using self-report questionnaires (pooled rate=31%, 95% CI 27% to 36%). The pooled PTSD prevalence among women living with HIV, MSM living with HIV and non-MSM men living with HIV were 35% (95% CI 28% to 43%), 33% (95% CI 29% to 38%) and 20% (95% CI 17% to 23%), respectively. Also, studies conducted with convenience sampling were more likely to have higher PTSD prevalence (pooled rate=32%, 95% CI 27% to 37%) than those using consecutive sampling (pooled rate=17%, 95% CI 10% to 24%).

###### 

Subgroup analyses of the prevalence of PTSD in PLWH

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Subgroup                       Number of studies           Positive PTSD screening (diagnosis)   Sample size (tested)   Pooled prevalence of PTSD (95% CI)   Heterogeneity (I^2^)   Between-group difference            
  ------------------------------ --------------------------- ------------------------------------- ---------------------- ------------------------------------ ---------------------- -------------------------- -------- ---------
  Geographic area\               High-income countries       23                                    1483                   6832                                 0.29 (0.25 to 0.34)    94.70%                     107.32   \<0.001
   \                                                                                                                                                                                                                      
                                                                                                                                                                                                                          

  Middle-income countries        10                          1077                                  3755                   0.27 (0.16 to 0.37)                  98.60%                                                     

  Low-income countries           5                           182                                   1156                   0.26 (0.07 to 0.45)                  98.30%                                                     

  Population group\              Women living with HIV       15                                    1282                   4190                                 0.35 (0.28 to 0.43)    96.10%                     26.99    \<0.001
   \                                                                                                                                                                                                                      
                                                                                                                                                                                                                          

  MSM living with HIV            3                           129                                   380                    0.33 (0.29 to 0.38)                  73.70%                                                     

  non-MSM male living with HIV   4                           165                                   754                    0.20 (0.17 to 0.23)                  89.10%                                                     

  Sampling                       Consecutive sampling        7                                     280                    2387                                 0.17 (0.10 to 0.24)    97.30%                     206.01   \<0.001

  Convenience sampling           20                          1260                                  4746                   0.32 (0.27 to 0.37)                  91.60%                                                     

  Data collection\               Self-report questionnaire   25                                    2197                   7812                                 0.31 (0.27 to 0.36)    95.70%                     297.01   \<0.001
                                                                                                                                                                                                                          

  Clinical interview             13                          545                                   3931                   0.22 (0.16 to 0.27)                  97.20%                                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MSM, post-traumatic stress disorder; PTSD, post-traumatic stress disorder.

Discussion {#s4}
==========

To the best of our knowledge, this is the first meta-analysis to provide the pooled estimated prevalence of PTSD among PLWH. A comprehensive search of the literature assessing the rate of comorbidity between PTSD and HIV-infection was performed, and 38 studies met the predefined criteria and were included in the meta-analysis. A total of 11 743 participants were involved, of which 2742 were identified with PTSD. The estimated pooled prevalence was 28% (95% CI 24% to 33%), which suggests a considerable burden of PTSD in the HIV-infected population. High heterogeneity across studies was detected, and factors such as differences in region, population characteristics, sampling and measurement were associated with the prevalence.

As indicated, the PTSD prevalence among PLWH found in this study (28%) far exceeded that among the general population (3.9%),[@R73] and was much higher than the prevalence of PTSD among other vulnerable groups in some previous studies. For example, the prevalence for cancer-related PTSD was 5.1%--15.3%[@R74]; in persons with chronic pain, the estimated mean prevalence of PTSD was 9.7%.[@R75] The pooled prevalence of PTSD among PLWH found in this study heightened the high rate of comorbidity between HIV infection and PTSD, which is consistent with previous demonstrations.[@R8] For PLWH, although depressive symptoms have been the focus of many studies, and 36% of PLWH were likely to have depression according to nationally representative data in the USA,[@R77] this pooled estimated prevalence of PTSD among PLWH showed that PTSD is also a common mental disorder among individuals living with HIV/AIDS. Therefore, the results of our study significantly underscore the importance of early assessment and trauma-directed psychological interventions for PLWH.

Undoubtedly, heterogeneity between studies is expected in such a relatively large topic of review. In this review, the estimated PTSD prevalence in PLWH varied widely (1.6%--54.1%) across studies and countries, which is also a common problem in the epidemiology of psychological and mental health disorders.[@R78] Consistent with the findings of previous research,[@R59] the majority of studies which have determined the incidence of HIV-related PTSD have been conducted in high-income countries (n=23). Compared with low-income countries, high-income countries reported relatively higher prevalence of PTSD. This tendency and the varied prevalence of PTSD among PLWH may be explained by the cross-cultural differences in attitudes towards HIV infection. Turan *et al*[@R80] found that the level of perceived HIV-related stigma in the community experienced by PLWH may cause adverse health and psychosocial outcomes. Social isolation and stigma might exacerbate symptoms of PTSD.[@R81] In high-income countries, PLWH may experience 'compound' or 'layered' stigma, where stigmatising beliefs are associated with HIV infection and related to sexual orientation, commercial sexual behaviours, etc.[@R82] Although, HIV-related stigma is highly burdensome in some middle-income countries, such as China,[@R83] the reported prevalence of PLWH with PTSD was lower compared with high-income countries. The differences between collectivism and individualism rooted in eastern and western culture may be an explanation.[@R85] It is worth noting that social context may influence the susceptibility of mental health disorders, and constitutes an important factor in perceived stigma among individuals with mental illness. Compared with high-income countries, stigmatising beliefs about the causes and presence of mental illness are still widespread in low-income and middle-income countries,[@R86] which may lead to less disease reporting. Caution must be applied, since there is a lack of studies investigating HIV-related PTSD in low-income (n=5) and middle-income (n=10) countries. In particular, detection of prevalence is associated with the representativeness and size of sample. In the context of low-income and middle-income countries, it could be argued that lower HIV testing rates may underestimate the PTSD prevalence and impact generalisability. Thus, more epidemiological studies are warranted to better understand and clarify the difference in PTSD prevalence among PLWH globally.

Subgroup analyses indicated that the prevalence of PTSD differed significantly when gender and sexual orientation were taken into consideration. Specifically, women living with HIV exhibited a higher prevalence of PTSD (35%) in comparison with both MSM (33%) and non-MSM male (20%) groups. This matches the pattern of prevalence in PTSD, in which being female is a risk factor associated with PTSD development.[@R16] As suggested by the aforementioned findings, MSM living with HIV may experience higher levels of stigma and trauma related to their sexual orientation.[@R30] Compared with heterosexual counterparts, MSM reported higher risk for suicidal ideation,[@R89] which also indicates greater psychological stress and mental health problems (ie, PTSD and depression). The findings that MSM and female HIV-infected individuals are at higher risk of developing PTSD may indicate that related health promotion campaigns should be directed to these groups. Clinicians should also take into consideration the PTSD susceptibility in different groups of HIV-infected populations during diagnoses. Notably, most eligible studies did not provide separate prevalence regarding the gender of participants, and only three studies identified PTSD prevalence among MSM living with HIV. Given that these data are from a small number of studies and/or participants, this finding should be interpreted with caution. Nonetheless, given the high prevalence of PTSD in this group, future efforts should be made to obtain more prevalence data on PTSD among MSM living with HIV.

In our study, we assessed methodological differences that may result in heterogeneity. Factors including sampling strategies (convenience vs consecutive) and measurement (self-report vs clinical interview) were evaluated by subgroup analyses. Among 38 studies providing estimated prevalence of PTSD, 7 reported participants were consecutively enrolled via self-referral from flyers describing the study or advertisements from HIV healthcare providers, and generated a lower pooled rate (17%) compared with the other 20 studies using convenience sampling (32%), although both sampling methods were non-probabilistic. An increase in reporting rate due to convenience sampling has also been found in another meta-analysis synthesising the HCV seroconversion rates in MSM living with HIV.[@R90] Convenience samples may allow researchers to select participants who are more likely to have PTSD symptoms and lead to overestimation, but given that only four studies were rated as high quality and limited description of study methods was detected in some studies, the reporting of epidemiology may not be sufficient to draw conclusions. Therefore, the appropriateness of calculating pooled prevalence estimates could be questioned, and the pooled prevalence estimate regarding the varied recruitment approaches of the studies should be interpreted with caution.

In this review, a total of 14 different tools were used to assess PTSD symptoms among PLWH across studies. Overall, the prevalence of PTSD screened by self-report instruments (31%) was higher than that assessed by clinical interview (22%). Although both measurements were in accordance with the diagnostic criteria (ie, DSM or ICD), clinical interviews most likely do a much better job of assessing symptoms carefully---for example, not counting symptoms that do not meet clinically meaningful thresholds, and self-report measures may inflate the prevalence estimates[@R91]; alternatively, subjects may be more comfortable reporting symptoms using self-report questionnaires (presumably paper or online surveys rather than face-to-face interviews). Screening or diagnosing with survey instruments is a common and practical method, especially in resource-limited regions. We found that, although a number of measures have been used to assess PTSD among PLWH, there is no tool designed for this population specifically. As the sensitivity and specificity of the measures may impact accurate PTSD detection, further research is required to identify a standardised measure accordingly to improve validity.

Certain limitations should be acknowledged in this meta-analysis. First, although minimal potential for publication bias was presumed as all data drawn for this review were from studies reporting estimated point prevalence without intervention, publication bias cannot be ruled out for there are a number of studies published in languages other than English and Chinese that were not included in this review. Second, the heterogeneity was high in the whole sample and most subgroups. Heterogeneity importantly influences the reliability and accuracy of a meta-analysis, and the only reliable method for acquiring correct inferences is careful selection of appropriate studies.[@R92] Even though strict eligibility criteria were employed in addressing PTSD prevalence in this study, it should be noted that getting HIV is only one possible traumatic event, and therefore it is possible that the PTSD experienced by participants in the selected studies was due to an event other than finding out they were HIV positive. Accordingly, we suggest that further studies assessing PTSD among PLWH include more detail on the specific traumas experienced by study participants. In addition, we have analysed the influences of region, population group, recruitment venue and measurement method, which explained some of the heterogeneity. However, the results should be interpreted with caution. Third, although some studies have indicated that several sociodemographic factors such as age may be associated with PTSD incidence among PLWH, we were unable to conduct subgroup analyses stratified by age due to the lack of detailed information reported in the published studies. As the quality of reporting could increase the susceptibility to bias, it is imperative for researchers to report their findings of observational studies in accordance with the appropriate guidelines, such as the Strengthening the Reporting of Observational Studies in Epidemiology checklist.

Conclusions {#s5}
===========

This review contributes to evidence on the quantitatively pooled prevalence of PTSD among PLWH. Stratified subgroups including geographic area, population group, sampling and measurement method were found to be significant factors accounting for the varied prevalence of PTSD among PLWH. More effective intervention strategies targeting PTSD among PLWH are urgently needed. Future efforts should be made to obtain countries' own PTSD prevalence data among PLWH as well as specific vulnerable minorities, which will provide a basis for public health policy, healthcare planning and resource allocation for PTSD intervention initiatives. Our study also suggests that more research using robust and comprehensive methodology is needed to provide rigorous evidence for designing the targeted psychological interventions.
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